Technology | October 26, 2011

Lantheus Awarded Premier Agreements For Ultrasound, MRI Contrast Agents

October 26, 2011 – Lantheus Medical Imaging announced it has been awarded three-year supplier contracts with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, in the category of cardiac ultrasound contrast media for its ultrasound contrast agent, Definity Vial for (perflutren lipid microsphere) Injectable Suspension, and its magnetic resonance angiography (MRA) blood pool imaging agent, Ablavar (gadofosveset trisodium).

The cardiac ultrasound contrast media contract award is a three-year sole-source supplier agreement, effective Dec. 1, 2011 through Nov. 30, 2014. The Ablavar contract award is a three-year supplier agreement, effective Jan. 1, 2012, through Dec. 31, 2014. These new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Definity and Ablavar .

Definity, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border cardiograms, and Ablavar, an MRA contrast agent indicated to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD), will both be offered to more than 2,500 hospitals nationwide and 76,000-plus healthcare sites. The contracts were awarded after a competitive bidding process that examined multiple factors, including pricing and clinical experience with Definity and Ablavar, as well as Lantheus’ support of the products.

For more information: www.lantheus.com, www.ablavar.com

Related Content

LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
September 19, 2018 — DiA Imaging Analysis Ltd.
Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems
Technology | Cardiovascular Ultrasound | August 22, 2018
August 22, 2018 — Philips recently announced the introduction of the Epiq CVx ...
Videos | Cardiovascular Ultrasound | July 10, 2018
DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the...
Videos | Cardiovascular Ultrasound | July 03, 2018
Michael Lanspa, M.D., director of critical care echocardiography services, Intermountain Medical Center, Salt Lake Ci
Videos | Cardiovascular Ultrasound | July 02, 2018
Lissa Sugeng, M.D., associate professor of medicine, director of echocardiography and of the Yale Echo Core Lab, Yale
Videos | Cardiovascular Ultrasound | July 02, 2018
This is an example of the a mitral valve with regurgitation imaged with 3-D echocardiography using the Siemens SC2000
Videos | Cardiovascular Ultrasound | June 28, 2018
Sunil Mankad, M.D., FASE, ASE 2018 meeting program chair and director of transesophageal echocardiography at Mayo Cli
Videos | Cardiovascular Ultrasound | June 28, 2018
This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology.
EchoMD AutoEF Software Improves Variability in Ejection Fraction Estimation
News | Cardiovascular Ultrasound | June 27, 2018
A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
Overlay Init